Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Iterum Therapeutics plc Ordinary Share (ITRM)

Pharmaceutical Preparations

https://www.iterumtx.com

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally. Its sulopenem program has the potential to offer a solution to the problem of antibiotic resistance and the toxicity limitations of existing agents. The company operates as a single business segment, which is the development and commercialization of innovative treatments for drug-resistant bacterial infections.

FITZWILLIAM COURT, 1ST FLOOR, LEESON CLOSE
DUBLIN 2, L2

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/25/2018

Market Cap

27,247,193

Shares Outstanding

13,420,000

Weighted SO

13,435,388

Total Employees

N/A

Upcoming Earnings

08/09/2024

Similar Tickers

ONTX --.--%

ADIL --.--%

DFFN --.--%

AEZS --.--%

TNXP --.--%

FBIO --.--%

EYEN --.--%

OCUP --.--%

GRTX --.--%

Beta

2.2490

Last Div

0.0000

Range

0.622-2.5

Chg

-0.0200

Avg Vol

227841

Mkt Cap

27247193

Exch

NASDAQ

Country

IE

Phone

353 1 669 4820

DCF Diff

2.2367

DCF

-1.0367

Div Yield

0.0000

P/S

10.3997

EV Multiple

-1.1769

P/FV

-1.8201

Div Yield %

0.0000

P/E

-0.7009

PEG

-0.0380

Payout

0.0000

Current Ratio

0.7726

Quick Ratio

0.7726

Cash Ratio

0.2966

DSO

27.1660

DIO

0.0000

Op Cycle

27.1660

DPO

336.7340

CCC

-309.5680

Gross Margin

0.6599

Op Margin

-14.6011

Pretax Margin

-10.6698

Net Margin

-10.8156

Eff Tax Rate

-0.0137

ROA

-1.9992

ROE

5.6578

ROCE

14.7078

NI/EBT

1.0137

EBT/EBIT

0.7308

EBIT/Rev

-14.6011

Debt Ratio

1.5242

D/E

-1.9797

LT Debt/Cap

-3.1700

Total Debt/Cap

2.0208

Int Coverage

-61.6023

CF/Debt

-1.9203

Equity Multi

-1.2988

Rec Turnover

13.4359

Pay Turnover

1.0839

Inv Turnover

0.0000

FA Turnover

6.2981

Asset Turnover

0.1848

OCF/Share

-2.5063

FCF/Share

-2.5063

Cash/Share

0.7079

OCF/Sales

-15.8341

FCF/OCF

1.0000

CF Coverage

-1.9203

ST Coverage

-3.1173

CapEx Coverage

-35642.6491

Div&CapEx Cov

-35642.6491

P/BV

-1.8201

P/B

-1.8201

P/S

10.3997

P/E

-0.7009

P/FCF

-0.6568

P/OCF

-0.4788

P/CF

-0.4788

PEG

-0.0380

P/S

10.3997

EV Multiple

-1.1769

P/FV

-1.8201

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 07, 08:30 Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023

Revenue Product Segmentation